Xin Lang Cai Jing·2025-09-04 12:34Core Viewpoint - The company reported strong financial performance for the first half of 2025, with significant year-on-year growth in revenue and net profit, outperforming major competitors in the insurance sector [1][2]. Financial Performance - The company achieved operating revenue of 70.041 billion yuan, representing a year-on-year increase of 26.0% [1]. - The net profit attributable to shareholders was 14.799 billion yuan, up 33.5% year-on-year, while competitors like PICC, Taiping, China Life, and Ping An reported growth rates of 16.9%, 11.0%, 6.9%, and a decline of 8.8%, respectively [1]. - The new business value (NBV) reached 6.182 billion yuan, reflecting a robust year-on-year growth of 58.4% [1]. Business Quality and Growth - The company reported original insurance premium income of 121.262 billion yuan, a year-on-year increase of 22.7% [2]. - First-year premiums for long-term insurance surged to 39.622 billion yuan, up 113.1% year-on-year, while first-year regular premium income for long-term insurance reached 25.528 billion yuan, increasing by 64.9% [2]. - The individual life insurance business maintained a 13-month persistency rate of 96.2%, up 1.2 percentage points year-on-year, and a 25-month persistency rate of 92.5%, up 6.9 percentage points year-on-year [2]. - The individual insurance channel had a workforce of 133,000, a decrease of 2.5% from the end of 2024, but the average monthly performance of agents improved [2]. Investment Performance - The company reported an annualized total investment return of 5.9%, an increase of 1.1 percentage points year-on-year, while the annualized net investment return was 3.0%, down 0.2 percentage points year-on-year [3]. - The asset allocation included 50.6% in bonds (up 2.1 percentage points from the previous year), 11.6% in stocks (up 10.2 percentage points), and 7.0% in funds (down 4.9 percentage points) [3]. - High-dividend OCI equity instruments increased to 37.466 billion yuan, a growth of 22% from the beginning of the year [3]. Investment Recommendation - The investment rating is maintained at Buy-A, with projected EPS for 2025-2027 at 8.80 yuan, 11.47 yuan, and 11.72 yuan, respectively [3]. - The company is assigned a 0.8x P/EV for 2025, with a corresponding six-month target price of 70.91 yuan [3].